Table 2.
Botanical drugs.
| Botanical Drugs | Inhibition mechanism | Refs. |
|---|---|---|
| TSF | Inhibition of ROS production and TXNIP expression | (155) |
| PN | NACHT ATPase inhibitor and Caspase-1 inhibitor | (156) |
| Tilianin | Regulation of the Nrf2/TXNIP/NLRP3 inflammasome pathway | (157) |
| Resveratrol | By regulating the combined effects of Sirt1 and Sirt6 | (158) |
| BBR | Inhibition of NLRP3 inflammasome activation | (159) |
| Swertiamarin | Inhibition of NOXs/ROS/NLRP3 signaling pathway | (160) |
| Salidroside | Inhibition of P2X7 receptor expression and regulation of AMPK/NLRP3 axis | (161, 162) |
| Ginsenoside | Inhibition of oxidative stress | (163) |